IMPACT EU investment in poverty-related neglected diseases 1 2 3 - - PowerPoint PPT Presentation

impact
SMART_READER_LITE
LIVE PREVIEW

IMPACT EU investment in poverty-related neglected diseases 1 2 3 - - PowerPoint PPT Presentation

SAVING LIVES AND CREATING IMPACT EU investment in poverty-related neglected diseases 1 2 3 What has the EU invested in How have developing countries What is the return on investment PRND R&D? benefitted? for Europe? EU Investment


slide-1
SLIDE 1

SAVING LIVES AND CREATING IMPACT

EU investment in poverty-related neglected diseases

slide-2
SLIDE 2
  • Levels of funding
  • Nature of funding
  • Health impact
  • Economic impact
  • Research capacity
  • Jobs created
  • Leveraged

investment

  • Scientific

excellence

  • Industrial

competitiveness

  • Health in the EU
  • Integration

Growth and competitiveness in the EU Health and prosperity in developing countries EU Investment in PRND R&D 2

How have developing countries benefitted?

3

What is the return on investment for Europe?

= +

1

What has the EU invested in PRND R&D?

slide-3
SLIDE 3

The EU invests €341 million a year in PRND R&D

15% OF ALL FUNDING FOR PRND R&D

1

What has the EU invested in PRND R&D?

slide-4
SLIDE 4

Top Funders

€93m 1st EC €87m 2nd UK €53m 3rd France

1

What has the EU invested in PRND R&D?

slide-5
SLIDE 5

Sweden

0.0054%

UK

0.0049%

Ireland

0.0047%

EU

0.0024% Finland 0.0004%

Denmark

0.0042%

France

0.0013%

Luxembourg

0.0032%

Belgium

0.0016%

Netherlands

0.0035%

Germany

0.0007% Italy 0.0002%

Spain

0.0013%

Member State Funding by GDP

USA

0.01%

Brazil

0.0017%

India

0.0017%

1

What has the EU invested in PRND R&D?

slide-6
SLIDE 6

MDG 1

Eradicate Extreme Poverty and Hunger

MDG 2

Achieve Universal Primary Education

MDG 3

Promote Gender Equality and Empower Women

MDG 4

Reduce Child Mortality

MDG 5

Improve Maternal Health

MDG 6

Combat HIV/AIDS, Malaria and other diseases

MDG 7

Ensure Environmental Sustainability

MDG 8

A Global Partnership for Development

Pharmaceutical Innovation 2

How have developing countries benefitted?

slide-7
SLIDE 7

EU investment has contributed to the creation of 43 new PRND products

2

How have developing countries benefitted?

slide-8
SLIDE 8

MALARIA

KEY PHARMACEUTICAL INNOVATIONS

1.COARTEM 2.ASAQ 3.EUARTESIM

2

How have developing countries benefitted?

INFECTS 216+ MILLION PEOPLE

KILLS AROUND 655,000 PEOPLE

Image Credit: Anne Heslop Photography

slide-9
SLIDE 9

359 products in development

43% involving European developers

FOR VACCINES ALONE, THERE ARE PROMISING CANDIDATES FOR

BURULI ULCER, TUBERCULOSIS AND SCHISTOSOMIASIS 2

How have developing countries benefitted?

slide-10
SLIDE 10

Medical Research Council, Gambia Medical Research Unit – Albert Schweitzer Hospital, Gabon Ifakara Health Institute, Tanzania Manhiça Health Research Centre, Mozambique International Centre for Diarrhoeal Disease Research, Bangladesh

2

How have developing countries benefitted?

Key Developing Country Research Institutions in Africa & Asia

slide-11
SLIDE 11

EU investment created more than 13,000 jobs

3

What is the return on investment for Europe?

slide-12
SLIDE 12

Two-thirds of Europe’s PRND R&D funding is invested back into Europe

3

What is the return on investment for Europe?

slide-13
SLIDE 13

€1 €2.05

Industry €0.53 Philanthropy €0.45 Other gov’ts €0.07

3

What is the return on investment for Europe?

slide-14
SLIDE 14

Top European PRND Research Institutes

Institut Pasteur Liverpool School of Tropical Medicine London School of Hygiene & Tropical Medicine Statens Serum Institute Institute of Tropical Medicine Swiss Tropical Institue of Public Health Karolinska Institute Royal Tropical Institute Barcelona Centre for International Health Research Heidelberg University University of Tübingen Bernhard Nocht Institute for Tropical Medicine

3

What is the return on investment for Europe?

slide-15
SLIDE 15

The European pharmaceutical industry invested six times more than the U.S. industry relative to annual revenues

6x

3

What is the return on investment for Europe?

slide-16
SLIDE 16

Opportunity: Horizon 2020

Increased PRND R&D investment under Horizon 2020 will benefit both developing countries and Europe

Opportunity: Horizon 2020

slide-17
SLIDE 17

Collaboration & partnerships Building Capacity in Developing Countries Quality Research Integrating Industry

= + + + +

Opportunity: Horizon 2020

EU Investment in PRND R&D

=

Growth and competitiveness in the EU Health and prosperity in developing countries

+

slide-18
SLIDE 18

Recommendations

1 Increase investments in PRND R&D including an increased commitment from the EC under Horizon 2020

Recommendations

slide-19
SLIDE 19

2 Retain and foster the distinctive benefits of its approach to funding PRND R&D

Recommendations

slide-20
SLIDE 20

3 Improve specific aspects of its investment in PRND R&D, to ensure greater efficiency, impact and value

Recommendations

slide-21
SLIDE 21

Thank you